Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Gelman AE, Zhang J, Choi Y, Turka LA.

J Immunol. 2004 May 15;172(10):6065-73.

2.

Toll-like receptors as adjuvant receptors.

Kaisho T, Akira S.

Biochim Biophys Acta. 2002 Feb 13;1589(1):1-13. Review.

3.

Functions of toll-like receptors: lessons from KO mice.

Akira S, Takeda K.

C R Biol. 2004 Jun;327(6):581-9. Review.

PMID:
15330257
4.

Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?

O'Neill LA.

Trends Immunol. 2002 Jun;23(6):296-300. Review.

PMID:
12072368
5.

A novel negative regulator for IL-1 receptor and Toll-like receptor 4.

Liew FY, Liu H, Xu D.

Immunol Lett. 2005 Jan 15;96(1):27-31. Review.

PMID:
15585304
6.

[Signal transduction of Toll-like receptors].

Matsuguchi T.

Nihon Rinsho. 2005 Apr;63 Suppl 4:109-14. Review. Japanese. No abstract available.

PMID:
15861643
7.

Role of Toll-like receptors in costimulating cytotoxic T cell responses.

Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirard JC, Röthlisberger P, Bachmann MF.

Eur J Immunol. 2003 Jun;33(6):1465-70. Review.

8.

Wanted: a molecular basis for specificity in toll-like receptor signal transduction.

O'Neill LA.

Mol Cell. 2002 Nov;10(5):969-71. Review. No abstract available.

9.

Modulation of γδ T cell responses by TLR ligands.

Wesch D, Peters C, Oberg HH, Pietschmann K, Kabelitz D.

Cell Mol Life Sci. 2011 Jul;68(14):2357-70. doi: 10.1007/s00018-011-0699-1. Epub 2011 May 11. Review.

PMID:
21560072
10.

TB, or not TB: that is the question -- does TLR signaling hold the answer?

Doherty TM, Arditi M.

J Clin Invest. 2004 Dec;114(12):1699-703. Review.

11.

Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Liu G, Zhang L, Zhao Y.

Clin Exp Immunol. 2010 May;160(2):168-75. doi: 10.1111/j.1365-2249.2010.04091.x. Epub 2010 Jan 29. Review.

12.

Toll-like receptor signaling in cell proliferation and survival.

Li X, Jiang S, Tapping RI.

Cytokine. 2010 Jan;49(1):1-9. doi: 10.1016/j.cyto.2009.08.010. Epub 2009 Sep 22. Review.

13.

The SIRP family of receptors and immune regulation.

Barclay AN, Brown MH.

Nat Rev Immunol. 2006 Jun;6(6):457-64. Review.

PMID:
16691243
14.

The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses.

Murshid A, Borges TJ, Lang BJ, Calderwood SK.

Front Immunol. 2016 Jun 13;7:226. doi: 10.3389/fimmu.2016.00226. eCollection 2016. Review.

15.

Antiinfective applications of toll-like receptor 9 agonists.

Krieg AM.

Proc Am Thorac Soc. 2007 Jul;4(3):289-94. Review.

16.

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.

Engel AL, Holt GE, Lu H.

Expert Rev Clin Pharmacol. 2011 Mar;4(2):275-89. doi: 10.1586/ecp.11.5. Review.

17.

Effects of Toll-like receptor signals in T-cell neoplasms.

Morrison C, Baer MR, Zandberg DP, Kimball A, Davila E.

Future Oncol. 2011 Feb;7(2):309-20. doi: 10.2217/fon.10.185. Review.

18.

CD4 T cell defects in the aged: causes, consequences and strategies to circumvent.

Zhang W, Brahmakshatriya V, Swain SL.

Exp Gerontol. 2014 Jun;54:67-70. doi: 10.1016/j.exger.2014.01.002. Epub 2014 Jan 15. Review.

19.

The potential for Toll-like receptors to collaborate with other innate immune receptors.

Mukhopadhyay S, Herre J, Brown GD, Gordon S.

Immunology. 2004 Aug;112(4):521-30. Review.

20.

Toll-like receptors in giant cell arteritis.

Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM.

Clin Immunol. 2005 Apr;115(1):38-46. Review.

PMID:
15870019

Supplemental Content

Support Center